AMLX Earnings Date: Nov 5, 2026 (Estimated) — Amylyx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is AMLX's next earnings date?
Amylyx Pharmaceuticals, Inc. (AMLX) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.38 on revenue of $59,429.
How did AMLX do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Amylyx Pharmaceuticals, Inc. posted EPS of -$0.39 versus the -$0.36 estimate, a miss of 11.4%. Revenue was $0. The stock's 1-day post-earnings move was +10.7%.
How much does AMLX stock move after earnings?
AMLX beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.3% (up or down) in the day after earnings.
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.36 | -0.39 | -11.43% | $0 | ❌ Miss | +10.71% | +6.87% | +55.42% |
| 2026-05-07 | Q1 2026 | -0.34 | -0.37 | -8.82% | $0 | ❌ Miss | -5.35% | -9.22% | -17.06% |
| 2026-03-03 | Q4 2025 | -0.33 | -0.30 | +9.09% | $0 | ✅ Beat | -7.78% | -6.47% | -9.15% |
| 2025-11-06 | Q3 2025 | -0.43 | -0.37 | +13.95% | $0 | ✅ Beat | -5.89% | -6.87% | +7.25% |
| 2025-03-04 | Q4 2024 | -0.59 | -0.55 | +6.78% | $-665,000 | ✅ Beat | +0.33% | +16.33% | +11.33% |
| 2024-11-07 | Q3 2024 | -0.71 | -0.53 | +25.35% | $416,000 | ✅ Beat | +5.14% | -8.68% | -17.36% |
| 2024-02-22 | Q4 2023 | 0.23 | 0.07 | -69.57% | $108.4M | ❌ Miss | +21.10% | +27.82% | -81.25% |
| 2023-08-10 | Q2 2023 | 0.10 | 0.31 | +210.00% | $98.2M | ✅ Beat | +2.03% | -4.53% | -4.20% |
Showing last 8 quarters.